Connecting and Collaborating on Cardiometabolic Care

The intersection of risk factors for diabetes, obesity, hyperlipidemia, the liver, and the cardiovascular system is becoming increasingly evident, and so is the mult-system impacts of lifestyle and specific pharmacotherapies for prevention and treatment. Episode guests Joseph Saseen, PharmD, MNLA, FACC, CLS, and Emily Bankhead, MSN, FNP-BC, describe the positive impacts of healthcare professionals working collaboratively, and to the top of their scope of licensure, to effectively address multi-system disorders.Related Resources2026 Multi-Society CKM Guideline [released after this episode recording]PCNA CE Course: Cardiometabolic Treatments for ObesitySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.